<DOC>
	<DOCNO>NCT02973516</DOCNO>
	<brief_summary>This study exploratory study aim collect data diagnosis efficacy ( sensitivity specificity ) P03277 triphasic liver image HCC subject suspect small nodule chronic liver disease . 30 subject include , HCC confirm previous enhance CT and/or MRI biopsy histology analysis . The standard reference diagnosis give site accord standard care adapt EASL/EORTC diagnostic criterion ( consider previous contrast enhance imaging ( CT and/or MRI ) and/or biopsy specimen analysis give on-site and/or recent AFP result available ) .</brief_summary>
	<brief_title>Proof Concept Study Concerning Efficacy P03277 MR Imaging HCC Diagnosis</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>Subject present liver cirrhosis chronic liver disease show previous liver biopsy combination clinical , endoscopic , biological , ultrasound parameter , elastography Subject present 1 maximum 3 untreated hepatic nodule ( ) less equal 3 cm ( long axis ) previously identify and/or characterize enhanced CT and/or MRI within maximum 21 day P03277 imaging , confirm HCC Subject present hepatic nodule 3 cm addition nodule ( ) less equal 3 cm Subject already treat HCC surgery thermal ablation resection coagulation area le 2 cm new nodule ( ) Subject previously treat transarterial chemoembolization Subject moderate severe renal impairment ( eGFR &lt; 60 mL/min/1.73 m2 ) base measurement do available within 7 day P03277 administration assess iodinated contrast agent administration , dialysis end stage renal disease ( ESRD )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>